Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 3
2005 4
2006 3
2007 6
2008 5
2009 2
2010 3
2011 4
2012 9
2013 4
2014 3
2015 1
2016 1
2019 2
2020 4
2021 1
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Gastric cancer.
Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem E. Catalano V, et al. Crit Rev Oncol Hematol. 2009 Aug;71(2):127-64. doi: 10.1016/j.critrevonc.2009.01.004. Epub 2009 Feb 20. Crit Rev Oncol Hematol. 2009. PMID: 19230702 Review.
Gastric cancer.
Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem E. Catalano V, et al. Crit Rev Oncol Hematol. 2005 Jun;54(3):209-41. doi: 10.1016/j.critrevonc.2005.01.002. Crit Rev Oncol Hematol. 2005. PMID: 15890270 Review.
Chemoembolization in colorectal liver metastases: the rebirth.
Fiorentini G, Aliberti C, Mulazzani L, Coschiera P, Catalano V, Rossi D, Giordani P, Ricci S. Fiorentini G, et al. Among authors: catalano v. Anticancer Res. 2014 Feb;34(2):575-84. Anticancer Res. 2014. PMID: 24510986 Review.
Movement and health beyond care, MoviS: study protocol for a randomized clinical trial on nutrition and exercise educational programs for breast cancer survivors.
Natalucci V, Ferri Marini C, De Santi M, Annibalini G, Lucertini F, Vallorani L, Panico AR, Sisti D, Saltarelli R, Donati Zeppa S, Agostini D, Gervasi M, Baldelli G, Grassi E, Nart A, Rossato M, Biancalana V, Piccoli G, Benelli P, Villarini A, Somaini M, Catalano V, Guarino S, Pietrelli A, Monaldi S, Sarti D, Barocci S, Flori M, Rocchi MBL, Brandi G, Stocchi V, Emili R, Barbieri E. Natalucci V, et al. Among authors: catalano v. Trials. 2023 Feb 22;24(1):134. doi: 10.1186/s13063-023-07153-y. Trials. 2023. PMID: 36814313 Free PMC article.
Changes in gut microbiota composition after 12 weeks of a home-based lifestyle intervention in breast cancer survivors during the COVID-19 lockdown.
Donati Zeppa S, Natalucci V, Agostini D, Vallorani L, Amatori S, Sisti D, Rocchi MBL, Pazienza V, Perri F, Villani A, Binda E, Panebianco C, Mencarelli G, Ciuffreda L, Ferri Marini C, Annibalini G, Lucertini F, Bartolacci A, Imperio M, Virgili E, Catalano V, Piccoli G, Stocchi V, Emili R, Barbieri E. Donati Zeppa S, et al. Among authors: catalano v. Front Oncol. 2023 Sep 1;13:1225645. doi: 10.3389/fonc.2023.1225645. eCollection 2023. Front Oncol. 2023. PMID: 37727203 Free PMC article.
Human equilibrative nucleoside transporter 1 (hENT1) levels predict response to gemcitabine in patients with biliary tract cancer (BTC).
Santini D, Schiavon G, Vincenzi B, Cass CE, Vasile E, Manazza AD, Catalano V, Baldi GG, Lai R, Rizzo S, Giacobino A, Chiusa L, Caraglia M, Russo A, Mackey J, Falcone A, Tonini G. Santini D, et al. Among authors: catalano v. Curr Cancer Drug Targets. 2011 Jan;11(1):123-9. doi: 10.2174/156800911793743600. Curr Cancer Drug Targets. 2011. PMID: 20578980 Free article. Review.
Effect of a lifestyle intervention program's on breast cancer survivors' cardiometabolic health: Two-year follow-up.
Natalucci V, Ferri Marini C, Lucertini F, Annibalini G, Sisti D, Vallorani L, Saltarelli R, Panico AR, Imperio M, Flori M, Busacca P, Villarini A, Donati Zeppa S, Agostini D, Monaldi S, Barocci S, Catalano V, Rocchi MBL, Benelli P, Stocchi V, Barbieri E, Emili R. Natalucci V, et al. Among authors: catalano v. Heliyon. 2023 Oct 29;9(11):e21761. doi: 10.1016/j.heliyon.2023.e21761. eCollection 2023 Nov. Heliyon. 2023. PMID: 38027927 Free PMC article.
Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity.
Chien J, Aletti G, Baldi A, Catalano V, Muretto P, Keeney GL, Kalli KR, Staub J, Ehrmann M, Cliby WA, Lee YK, Bible KC, Hartmann LC, Kaufmann SH, Shridhar V. Chien J, et al. Among authors: catalano v. J Clin Invest. 2006 Jul;116(7):1994-2004. doi: 10.1172/JCI27698. Epub 2006 Jun 8. J Clin Invest. 2006. PMID: 16767218 Free PMC article.
64 results